Neuromodulation Devices: Can Adaptive Therapy Expand Treatment Options?
Frost & Sullivan Podcasts
This episode of Frost & Sullivan’s Growth Podcast explores how neuromodulation is advancing through adaptive stimulation, expanding clinical applications, and new approaches to patient care. As companies move beyond traditional symptom management, clinical evidence, reimbursement, and patient access will shape the next phase of adoption.
👉 How are AI and closed-loop systems changing neuromodulation treatment?
👉 What sets leading companies such as Medtronic, Saluda Medical, and Inspire Medical Systems apart?
👉 Where can device manufacturers find new growth opportunities across treatment applications and care settings?
Designed for healthcare leaders, medical device executives, neuroscience researchers, and digital health innovators.
Explore related research at frost.com and store.frost.com, or connect with our team at hello@frost.com.
Loading